drugset / Trial / NCT06181513
Probiotics in Mild Alzheimer's Disease
Phase 0
Recruiting
40 enrolled
University of Nicosia
Cyprus Institute of Neurology and Genetics · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The main objective is to investigate whether administration of probiotics to patients with mild Alzheimer's Disease (AD) reduces neuroinflammation, improves cognitive function and modifies neurophysiological measures, compared to a patient group that receives placebo (no active probiotics).
Timeline
- Start
- 2022-12-19
- Primary completion
- 2025-07-01
- Completion
- 2025-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Probiotic Blend Capsule | Unknown | 2e+07 unknown | Oral |